Review of 2022 PSOGI/RENAPE Consensus on HIPEC.

Détails

Demande d'une copieDemande d'une copie
ID Serval
serval:BIB_8E1A0E6719D5
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
UNIL/CHUV
Titre
Review of 2022 PSOGI/RENAPE Consensus on HIPEC.
Périodique
Journal of surgical oncology
Auteur⸱e⸱s
Kusamura S., Bhatt A., van Der Speeten K., Kepenekian V., Hübner M., Eveno C., de Hingh I., Delhorme J.B., Taibi A., Villeneuve L., Dico R.L., Moran B., Govaerts K., Zivanovic O., Brennan D., Nadeau C., Van Driel W., Bakrin N., Piso P., Verwaal V.J., González-Moreno S., Alyami M., Sgarbura O., Rau B., Deraco M., Glehen O.
ISSN
1096-9098 (Electronic)
ISSN-L
0022-4790
Statut éditorial
In Press
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: aheadofprint
Résumé
The 2022 PSOGI (Peritoneal Surface Oncology Group International) and RENAPE (French Network for Rare Peritoneal Malignancies) consensus on hyperthermic intraperitoneal chemotherapy (HIPEC) was a comprehensive effort aimed at standardizing treatment protocols for various peritoneal malignancies. This initiative is critical due to the wide range of technical variations in HIPEC procedures and the resulting need for standardization to ensure consistent and effective patient care and meaningful audit of multicenter data.
Mots-clé
HIPEC regimens, consensus, hyperthermic intraperitoneal chemotherapy, peritoneal surface malignancies
OAI-PMH
oai:serval.unil.ch:BIB_8E1A0E6719D5
DOI
10.1002/jso.27885
Pubmed
39285659
Web of science
001314035000001
Open Access
Oui
Création de la notice
20/09/2024 15:17
Dernière modification de la notice
02/11/2024 7:10
Données d'usage